VP Business Development & Operations,
Adrien is currently VP Business Development & Operations at Orchard Therapeutics. He was previously Executive Director, Corporate Strategy and Development at AstraZeneca and a member of the Board of Directors of Corvidia Therapeutics. Prior to AstraZeneca, Adrien spent 9 years at GSK and his most recent experience was Strategy & Operations Director in the Rare Diseases unit. His experience at GSK also encompasses various European and global roles in R&D portfolio and commercial analysis. He started his career as a biotechnology strategy consultant in Paris (France). Adrien holds an engineering degree from Supelec (Paris, France) and a MSc in Engineering and Physical Science in Medicine from Imperial College (London, UK).